Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2011 - 2026)

Acadia Pharmaceuticals' Amortizatization of Intangibles history runs 16 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles rose 28.64% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $5.4 million (down 54.04% YoY), while the FY2025 annual figure was $5.4 million, down 63.75% from the prior year.
• Amortizatization of Intangibles was $2.7 million for Q1 2026 at Acadia Pharmaceuticals, up from -$2.7 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $5.0 million in Q4 2024 to a low of -$2.7 million in Q4 2025.
• Historically, Amortizatization of Intangibles has averaged $1.6 million across 5 years, with a median of $2.1 million in 2025.
• Biggest YoY gain for Amortizatization of Intangibles was 848.44% in 2023; the steepest drop was 302.01% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at -$642000.0 in 2022, then surged by 848.44% to $4.8 million in 2023, then advanced by 3.81% to $5.0 million in 2024, then tumbled by 154.99% to -$2.7 million in 2025, then soared by 199.23% to $2.7 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $2.7 million (Q1 2026), -$2.7 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.